Prevalence and Clinical Outcomes for Patients With ALK-Positive Resected Stage I to III Adenocarcinoma: Results From the European Thoracic Oncology Platform Lungscape Project

Fiona H. Blackhall, Solange Peters, Lukas Bubendorf, Urania Dafni, Keith M. Kerr, Henrik Hager, Alex Soltermann, Kenneth J. O'Byrne, Christoph Dooms, Aleksandra Sejda, Javier Hernandez-Losa, Antonio Marchetti, Spasenija Savic, Qiang Tan, Erik Thunnissen, Ernst-Jan M. Speel, Richard Cheney, Daisuke Nonaka, Jeroen de Jong, Miguel MartorellIgor Letovanec, Rafael Rosell, Rolf A. Stahel*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

117 Citations (Web of Science)
Original languageEnglish
Pages (from-to)2780-+
JournalJournal of Clinical Oncology
Issue number25
Publication statusPublished - 1 Sep 2014

Cite this